Literature DB >> 8389670

DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls.

D K Scates1, A D Spigelman, K P Nugent, R K Phillips, S Venitt.   

Abstract

Patients with familial adenomatous polyposis (FAP) have a high risk of developing duodenal adenomas and carcinomas. The distribution of these neoplasms resembles mucosal exposure to bile, suggesting that bile may play a role in adenoma development. Our previous results, using DNA adducts detected by 32P-postlabelling as an index of genotoxicity, have supported this hypothesis. We found significantly higher adduct labelling in the duodenum of FAP patients than in the duodenum of control patients and significantly higher labelling in the small bowel of rats gavaged with FAP bile than in rats given control bile. We have now investigated the ability of human bile to form adducts with DNA in vitro. Bile obtained from the gallbladder of 18 FAP patients immediately before colectomy, and from 18 control patients, was incubated with salmon sperm DNA in solution at 37 degrees C for 1 h, after which the purified DNA was analysed for DNA adducts, using the nuclease P1 method of 32P-postlabelling. Relative adduct labelling values (RAL, adducts per 10(9) nucleotides) produced by FAP bile samples were significantly higher than RAL values produced by control bile samples (medians 197 versus 86, P = 0.0016, Mann-Whitney test). We found a consistent pattern of adduct labelling, varying in intensity between samples. Adduct spots were eluted from TLC plates and analyzed by reverse-phase HPLC. Each major spot gave several peaks that were consistent between bile samples from different patients and were similar in FAP and control bile. These results indicate that bile from FAP and control patients contains similar, directly acting genotoxic compounds but that levels are higher in FAP than in control patients. This suggests that bile from FAP patients is more genotoxic than bile from control patients. Incubation of bile with free-radical scavengers and deconjugating enzymes failed to influence adduct labelling in this system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389670     DOI: 10.1093/carcin/14.6.1107

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis.

Authors:  James R A Skipworth; Clare Morkane; Dimitri Aristotle Raptis; Soumil Vyas; Steven W Olde Damink; Charles J Imber; Stephen P Pereira; Massimo Malago; Nicholas West; Robin K S Phillips; Sue K Clark; Arjun Shankar
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

2.  Caffeine phenotyping in patients with familial adenomatous polyposis may shed light on sporadic colon cancer and acetylator status.

Authors:  M R Welfare; M F Bassendine; M R Welfare; A K Daly
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

Review 3.  Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.

Authors:  Michelle C Gallagher; Robin K S Phillips; Steffen Bulow
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 4.  Familial adenomatous polyposis: an update.

Authors:  A Wyman; A J Shorthouse
Journal:  J R Soc Med       Date:  1996-04       Impact factor: 18.000

5.  High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis.

Authors:  D K Scates; S Venitt; R K Phillips; A D Spigelman
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 6.  Management of advanced duodenal polyposis in familial adenomatous polyposis.

Authors:  C Soravia; T Berk; G Haber; Z Cohen; S Gallinger
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

7.  DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma.

Authors:  S A Khan; P L Carmichael; S D Taylor-Robinson; N Habib; H C Thomas
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

8.  Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.

Authors:  A D Spigelman; K C Farmer; S Oliver; K P Nugent; P N Bennett; L J Notarianni; P Dobrocky; R K Phillips
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

9.  Letters.

Authors: 
Journal:  Ulster Med J       Date:  2016-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.